VRT-532 structure
|
Common Name | VRT-532 | ||
---|---|---|---|---|
CAS Number | 38214-71-0 | Molecular Weight | 250.29500 | |
Density | 1.213g/cm3 | Boiling Point | 472.9ºC at 760 mmHg | |
Molecular Formula | C16H14N2O | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 239.8ºC | |
Symbol |
GHS05, GHS07 |
Signal Word | Danger |
Use of VRT-532VRT-532 (CFpot-532) is a potent is a potent CFTR modulator. VRT-532 enhances channel activity in G551D-CFTR and intrinsic ATPase activity of G551D-CFTR. VRT-532 has the potential for the research of cystic fibrosis[1][2]. |
Name | 4-Methyl-2-(5-phenyl-1H-pyrazol-3-yl)phenol |
---|---|
Synonym | More Synonyms |
Description | VRT-532 (CFpot-532) is a potent is a potent CFTR modulator. VRT-532 enhances channel activity in G551D-CFTR and intrinsic ATPase activity of G551D-CFTR. VRT-532 has the potential for the research of cystic fibrosis[1][2]. |
---|---|
Related Catalog | |
In Vitro | VRT-532 (15 µM) 直接结合重组的 G551D-CFTR 并改变其 ATP 酶活性[1]。 |
References |
Density | 1.213g/cm3 |
---|---|
Boiling Point | 472.9ºC at 760 mmHg |
Molecular Formula | C16H14N2O |
Molecular Weight | 250.29500 |
Flash Point | 239.8ºC |
Exact Mass | 250.11100 |
PSA | 48.91000 |
LogP | 3.75770 |
Index of Refraction | 1.643 |
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H318 |
Precautionary Statements | P280-P305 + P351 + P338 |
RIDADR | NONH for all modes of transport |
~% VRT-532 CAS#:38214-71-0 |
Literature: Agrawal, Nitin N.; Soni Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2007 , vol. 46, # 3 p. 532 - 534 |
~% VRT-532 CAS#:38214-71-0 |
Literature: Garcia, Heremengildo; Iborra, Sara; Miranda, Miguel A.; Morera, Isabel M.; Primo, Jaime Heterocycles, 1991 , vol. 32, # 9 p. 1745 - 1755 |
~% VRT-532 CAS#:38214-71-0 |
Literature: Reddy, N. J.; Sharma, T. C. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1985 , vol. 24, p. 715 - 718 |
~% VRT-532 CAS#:38214-71-0 |
Literature: Alkhouri, Bashar; Denning, Robert A.; Chiaw, Patrick Kim; Eckford, Paul D.W.; Yu, Wilson; Li, Canhui; Bogojeski, Jovanka J.; Bear, Christine E.; Viirre, Russell D. Journal of Medicinal Chemistry, 2011 , vol. 54, # 24 p. 8693 - 8701 |
~% VRT-532 CAS#:38214-71-0 |
Literature: Alkhouri, Bashar; Denning, Robert A.; Chiaw, Patrick Kim; Eckford, Paul D.W.; Yu, Wilson; Li, Canhui; Bogojeski, Jovanka J.; Bear, Christine E.; Viirre, Russell D. Journal of Medicinal Chemistry, 2011 , vol. 54, # 24 p. 8693 - 8701 |
~% VRT-532 CAS#:38214-71-0 |
Literature: Alkhouri, Bashar; Denning, Robert A.; Chiaw, Patrick Kim; Eckford, Paul D.W.; Yu, Wilson; Li, Canhui; Bogojeski, Jovanka J.; Bear, Christine E.; Viirre, Russell D. Journal of Medicinal Chemistry, 2011 , vol. 54, # 24 p. 8693 - 8701 |
~% VRT-532 CAS#:38214-71-0 |
Literature: Sharma, T. C.; Bokadia, M. M.; Reddy, N. J. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1980 , vol. 19, # 3 p. 228 - 229 |
~% VRT-532 CAS#:38214-71-0 |
Literature: Sharma, T. C.; Bokadia, M. M.; Reddy, N. J. Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1980 , vol. 19, # 3 p. 228 - 229 |
4-heptyl-2-(1(2)H-tetrazol-5-yl)-phenol |
Phenol,4-heptyl-2-(1H-tetrazol-5-yl) |
5-(2-hydroxy-5-methylphenyl)-3-phenylpyrazole |
5-(2-hydroxy-5-heptylphenyl)tetrazole |
3-(2-hydroxy-5-methylphenyl)-5-phenylpyrazole |
5-(2-Hydroxy-5-heptylphenyl)tetrazol |